DSM-Firmenich AG (LON:0AC9)
London · Delayed Price · Currency is GBP · Price in EUR 69.08
-0.38 (-0.54%)
At close: Feb 11, 2026
DSM-Firmenich AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,034 | 12,799 | 10,627 | 8,390 | 7,269 | |
Revenue Growth (YoY) | -29.42% | 20.44% | 26.66% | 15.42% | -10.33% |
Cost of Revenue | 5,504 | 8,554 | 8,016 | 5,700 | 4,657 |
Gross Profit | 3,530 | 4,245 | 2,611 | 2,690 | 2,612 |
Selling, General & Admin | - | 2,848 | 2,535 | 1,772 | 1,649 |
Research & Development | - | 888 | 652 | 295 | 274 |
Other Operating Expenses | 2,819 | - | -16 | -29 | -21 |
Operating Expenses | 2,819 | 3,736 | 3,171 | 2,038 | 1,902 |
Operating Income | 711 | 509 | -560 | 652 | 710 |
Interest Expense | -143 | -162 | -138 | -104 | -92 |
Interest & Investment Income | - | 70 | 95 | 22 | 3 |
Earnings From Equity Investments | -108 | -5 | -6 | 12 | 16 |
Currency Exchange Gain (Loss) | - | -41 | -86 | -20 | -8 |
Other Non Operating Income (Expenses) | - | 1 | -26 | -1 | -9 |
EBT Excluding Unusual Items | 460 | 372 | -721 | 561 | 620 |
Merger & Restructuring Charges | - | -39 | -59 | -3 | -20 |
Gain (Loss) on Sale of Investments | - | 5 | -1 | -7 | 326 |
Gain (Loss) on Sale of Assets | - | 47 | 17 | 31 | 13 |
Legal Settlements | - | - | - | - | 2 |
Other Unusual Items | - | 21 | 57 | 5 | 2 |
Pretax Income | 460 | 427 | -654 | 599 | 953 |
Income Tax Expense | 118 | 147 | -18 | 124 | 123 |
Earnings From Continuing Operations | 342 | 280 | -636 | 475 | 830 |
Earnings From Discontinued Operations | -1,381 | - | 2,789 | 1,240 | 850 |
Net Income to Company | -1,039 | 280 | 2,153 | 1,715 | 1,680 |
Minority Interest in Earnings | -42 | -30 | -16 | -15 | -4 |
Net Income | -1,081 | 250 | 2,137 | 1,700 | 1,676 |
Preferred Dividends & Other Adjustments | 26 | - | 6 | 6 | 6 |
Net Income to Common | -1,107 | 250 | 2,131 | 1,694 | 1,670 |
Net Income Growth | - | -88.30% | 25.71% | 1.43% | 231.23% |
Shares Outstanding (Basic) | 259 | 265 | 233 | 173 | 173 |
Shares Outstanding (Diluted) | 259 | 265 | 233 | 173 | 173 |
Shares Change (YoY) | -2.00% | 13.37% | 34.68% | -0.06% | 0.56% |
EPS (Basic) | -4.27 | 0.94 | 9.14 | 9.80 | 9.67 |
EPS (Diluted) | -4.27 | 0.94 | 9.14 | 9.77 | 9.63 |
EPS Growth | - | -89.71% | -6.47% | 1.45% | 233.22% |
Free Cash Flow | 681 | 1,133 | 710 | 459 | 994 |
Free Cash Flow Per Share | 2.63 | 4.28 | 3.04 | 2.65 | 5.73 |
Dividend Per Share | 2.500 | 2.500 | 2.500 | 2.530 | 2.500 |
Dividend Growth | - | - | -1.19% | 1.20% | 4.17% |
Gross Margin | 39.07% | 33.17% | 24.57% | 32.06% | 35.93% |
Operating Margin | 7.87% | 3.98% | -5.27% | 7.77% | 9.77% |
Profit Margin | -12.25% | 1.95% | 20.05% | 20.19% | 22.97% |
Free Cash Flow Margin | 7.54% | 8.85% | 6.68% | 5.47% | 13.68% |
EBITDA | 1,622 | 1,599 | 345 | 1,234 | 1,305 |
EBITDA Margin | 17.95% | 12.49% | 3.25% | 14.71% | 17.95% |
D&A For EBITDA | 911 | 1,090 | 905 | 582 | 595 |
EBIT | 711 | 509 | -560 | 652 | 710 |
EBIT Margin | 7.87% | 3.98% | -5.27% | 7.77% | 9.77% |
Effective Tax Rate | 25.65% | 34.43% | - | 20.70% | 12.91% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.